United States Deep Brain Stimulation Market in Parkinson's Disease Poised for Remarkable Growth through 2029
04 juil. 2024 10h19 HE
|
Research and Markets
Dublin, July 04, 2024 (GLOBE NEWSWIRE) -- The "United States Deep Brain Stimulation In Parkinson's Disease Market, By Region, Competition, Forecast and Opportunities, 2019-2029F" report has been...
Parkinson's Disease Industry Assessment and Forecast 2023-2032
24 juil. 2023 05h33 HE
|
Research and Markets
Dublin, July 24, 2023 (GLOBE NEWSWIRE) -- The "Parkinson's Disease Market Insights, Epidemiology, and Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. This report...
US Parkinson's Disease Market Landscape to 2030: Epidemiology, Case Reports, Marketed & Emerging Drugs, Unmet Needs, KOL Views, Major Players
21 déc. 2021 09h23 HE
|
Research and Markets
Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The "Parkinson's Disease - US Market Insight, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. The...
Global Anti-Parkinson Drugs Market Report 2021-2030 Featuring Major Players - GlaxoSmithKline, Pfizer, Merck, Novartis, Roche, UCB S.A, Teva Pharmaceuticals, AbbVie and Mylan
16 juin 2021 07h23 HE
|
Research and Markets
Dublin, June 16, 2021 (GLOBE NEWSWIRE) -- The "Anti-Parkinson Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering....
Global Parkinson's Disease Treatment Industry (2020 to 2027) - Market Trajectory & Analytics
17 mars 2021 06h23 HE
|
Research and Markets
Dublin, March 17, 2021 (GLOBE NEWSWIRE) -- The "Parkinson's Disease Treatment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the...
Global Anti-Parkinson Drugs Market Report 2020: COVID-19, Growth and Change - Forecast to 2030
03 févr. 2021 03h43 HE
|
Research and Markets
Dublin, Feb. 03, 2021 (GLOBE NEWSWIRE) -- The "Anti-Parkinson Drugs Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering....